medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2017, Number 1

<< Back Next >>

Rev Cubana Hematol Inmunol Hemoter 2017; 33 (1)

Five decades of molecular biology and cytogenetic applied to cuban hematology

Garrote SH, Lavaut-Sánchez K, Amor VAM, Díaz AC, Fernández ML, Ruiz MV, Hernández AN, Rivero JRA

Language: Spanish
References: 14
Page: 1-8
PDF size: 104.33 Kb.


ABSTRACT

Molecular biology (MB) is a science that has revolutionized scientific development in recent years. It has also increasing progressively at the Institute of Hematology and Immunology (IHI) as adapting to technological advances and international scientific context. Its history dates back to 1966, with the IHI creation and subsequently the MB laboratory. Since then they have been many achievements in the field of diagnosis and research in Hematology. In 2012, the MB department with the cytogenetic laboratory was part of the Center for Advanced Technologies; an area with modern technology that has allowed change old studies by updated molecular techniques, ensuring greater speed and reliability of results. Techniques such as extraction and quantification of nucleic acids (NA), capillary electrophoresis and the FISH (Fluorescence in Situ Hybridization) were introduced, and modern thermocyclers for polymerase chain reaction (PCR), materials and reagents were acquired too. In these 50 years, 5 460 patients have been benefited to date. We study about 10 molecular markers, 12 FISH study, in addition to conventional karyotyping and chimerism studies in the MB lab at this moment. It has gone an annual average of 317 patients in the last 5 years. We have highly qualified professionals, which has made possible to lead and collaborate on national and international research, publishing numerous scientific articles, obtain relevant prizes of science and technology forum and directly contribute to the residents' formation in Hematology. Our future perspectives include the new technologies incorporation such as real-time PCR and sequencing, to complete a similar diagnostic level to any prestigious international center so we can provide quality service to our patients.


REFERENCES

  1. Martínez-Antuña G, Hernández-Hernández A, Corral AbascalL, Muñiz Fernández A, Hernández Martínez A. Biología molecular en hemoglobinopatías y hemopatías malignas. Rev Cubana Hematol Inmunol Hemoter. 1996; 12(2):81-5

  2. Amor-Vigil AM, Martínez-Antuña G, Lavaut-Sánchez K, Pérez-Diez de los Ríos G, Hernández-Martínez A, Estrada-del Cueto M. Resultados relevantes en biología molecular, enzimopatías y citogenética en el período 1996-2010. Rev Cubana HematolInmunolHemoter [Internet]. 2011 Mar [citado 2016 Ago 01]; 27(1):Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 02892011000100004&lng=es

  3. van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999 Dec; 13(12):1901-28.

  4. Amaru R, Peñaloza R, Miguez H, Torres G, Cuevas H. UMSAgen, método para la extracción simultánea de RNA y DNA para diagnóstico molecular. Rev. Cuadernos. 2008; 53(1):38-43.

  5. Eldh M, Lotvall J, Malmhall C, Ekstrom K. Importance of RNA isolation methods for analysis of exosomal RNA: evaluation of different methods. MolImmunol. 2012 Apr;50(4):278-86.

  6. Díaz-Alonso C, Garrote-Santana H, Amor-Vigil AM, Suárez-González Y, Fernández- Martínez L, Ruiz-Moleón V. Nuevos métodos de extracción de ácidos ribonucleicos (ARN): herramientas básicas en la biología molecular. Rev Cubana Hematol Inmunol Hemoter [revista en Internet]. 2015 [citado 2015 Nov 24]; 31(4): Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/349

  7. Diaz Alonso C, Garrote Santana H, Amor Vigil AM, Suárez González Y, González- Mugica Romero R. Cuantificación de ácido ribonucleico para la realización de la técnica en el IHI.. Rev Cubana Hematol Inmunol Hemot [revista en Internet]. 2013 [citado 2016 Ago 1]; 29(3): Disponible en: http://www.revhematologia.sld.cu/index.php/hih/article/view/81

  8. Kostal V, Katzenmeyer J, Arriaga J. Capillary electrophoresis in bioanalysis. Anal Chem. 2008; 80: 4533-50.

  9. Campbell LJ, OeiP, BrookwellR, ShorttJ, Eaddy N, Ng A et al. FISH Detection of PML-RARA Fusion in ins(15;17) Acute PromyelocyticLeukaemia Depends on Probe Size. Biomed Res Int. 2013 Mar; 2013:1-4 doi: 10.1155/2013/164501

  10. Hu L, Ru K, Zhang L, Huang Y, Zhu X, Liu H, et al. Fluorescence in situ hybridization (FISH): an increasingly demanded tool for biomarker research and personalized medicine. Biomark Res. 2014 Feb 5; 2(1):3.

  11. Venditti A, Del Principe M I, Maurillo L, Buccisano F, Amadori S. Minimal residual disease detection in pediatric acute myeloid leukemia: does flow cytometry score a point over molecular biology? Transl Pediatr . 2013 Jan; 2(1):43-45.

  12. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010 Oct; 11(10):685-96.

  13. Arber DA, OraziA, HasserjianR, ThieleJ, BorowitzM J, Le Beau M et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.Blood. 2016 May; 127 (20): 2391-405.

  14. Swerdlow SH, Campo E, Pileri SA, Lee Harris N,Stein H,Siebert R et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.Blood. 2016 May; 127 (20): 2375-90.




2020     |     www.medigraphic.com